Epidermal METTL1‐Mediated m7G Modification Drives Psoriatic Inflammation by Stabilizing Bdkrb1 and Orchestrating Neutrophil Recruitment
Advanced Science · 2026
DOI: 10.1002/advs.75970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Psoriasis, Neutrophil Infiltration, Methyltransferases, Inflammation. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Hebei, Hebei Natural Science Foundation.
Abstract (Originalsprache)
The functional significance of RNA modifications, specifically N7‐methylguanosine (m7G), in inflammatory conditions such as psoriasis remains not fully elucidated. This study demonstrates that methyltransferase‐like 1 (METTL1), an m7G methyltransferase, is significantly upregulated in epidermal keratinocytes of human psoriatic lesions and imiquimod (IMQ)‐induced murine models. Utilizing mice with an inducible keratinocyte‐specific Mettl1 deletion ( Mettl1 fl/fl Krt14 ‐Cre ERT2 ), the research reveals significantly attenuated psoriasiform inflammation and decreased neutrophil infiltration relative to Mettl1 fl/fl counterparts. Mechanistically, METTL1 drives inflammation by augmenting Bdkrb1 mRNA stability through m7G modification. This stabilization leads to elevated bradykinin receptor B1 (BDKRB1) protein expression, which activates the p38 mitogen‐activated protein kinase (MAPK) pathway in keratinocytes, promoting the secretion of key proinflammatory C‐X‐C motif chemokine ligand (CXCL) chemokines and robust neutrophil chemotaxis. Crucially, both in vivo genetic BDKRB1 overexpression and pharmacological BDKRB1 activation successfully rescue the attenuated inflammatory phenotype in Mettl1 ‐deficient mice, firmly validating this specific signaling cascade. Conversely, pharmacological inhibition of the METTL1–BDKRB1 axis effectively mitigates psoriasiform inflammation. Collectively, these data establish that METTL1 modulates psoriasis by fostering p38‐dependent chemokine production and neutrophil recruitment, identifying the METTL1–BDKRB1 axis as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.
- Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, Anhui, China.
- Collaborative Innovation Center of Complex and Severe Skin Disease, Anhui Medical University, Hefei, Anhui, China.
- North China University of Science and Technology Affiliated Hospital, Tangshan, China.
- North China University of Science and Technology, Tangshan, Hebei, China.
ORCID-Profile: Yang Han
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Hebei
- Hebei Natural Science Foundation
- Science and Technology Project of Hebei
- Science Research Project of Hebei Education Department
Zitieren
APA
Zhang, C., Lu, J., Yan, S., Wang, Y., Li, Z., Chen, W., Han, Y., Zhang, Z., Yu, Y., Zhen, Q., & Sun, L. (2026). Epidermal METTL1‐Mediated m7G Modification Drives Psoriatic Inflammation by Stabilizing Bdkrb1 and Orchestrating Neutrophil Recruitment. Advanced Science. https://doi.org/10.1002/advs.75970
Vancouver
Zhang C, Lu J, Yan S, Wang Y, Li Z, Chen W, et al. Epidermal METTL1‐Mediated m7G Modification Drives Psoriatic Inflammation by Stabilizing Bdkrb1 and Orchestrating Neutrophil Recruitment. Advanced Science. 2026. doi:10.1002/advs.75970
BibTeX
@article{Zhang2026,
author = {Zhang, Chang and Lu, Jiayi and Yan, Sihao and Wang, Yirui and Li, Zhuo and Chen, Weiwei and Han, Yang and Zhang, Ziyan and Yu, Yafen and Zhen, Qi and Sun, Liangdan},
title = {Epidermal METTL1‐Mediated m7G Modification Drives Psoriatic Inflammation by Stabilizing Bdkrb1 and Orchestrating Neutrophil Recruitment},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75970}
}
EUVIMED